Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
Therapeutic outcomes of oral cefcapene in meibomitis-related keratoconjunctivitis: A Propensity-matched cohort study
Ella Seo Yeon Park1,2, Hyunmin Ahn1,3, Kyoung Yul Seo1
1Department of Ophthalmology, The Institute of Vision Research, Yonsei University College of Medicine, Seoul, South Korea.
Purpose:
The purpose of the study was to evaluate the clinical characteristics and therapeutic response in patients with meibomitis-related keratoconjunctivitis (MRKC) who were treated with oral cefcapene pivoxil hydrochloride hydrate, and to determine factors associated with favorable outcomes.
Materials And Methods:
A retrospective analysis was conducted on 62 patients with MRKC, including 31 patients who received a 14-day course of oral cefcapene (100 mg three times daily) in combination with standard warm compression and lid hygiene. These patients were 1:1 propensity score-matched with 31 controls who underwent warm compression and lid hygiene, based on age, sex, meibomian gland expressibility, and meibum quality. Baseline characteristics and posttreatment outcomes - including corneal staining score (CSS) and ocular surface disease index (OSDI) - were compared between the groups.
Results:
One month after treatment, mean CSS was significantly lower in the cefcapene group (0.55 ± 0.65) compared with controls (0.86 ± 0.44, P = 0.032*). The cefcapene group also showed higher rates of complete corneal staining resolution (CSS = 0) and greater OSDI improvement, although these outcomes did not reach statistical significance.
Conclusion:
Adjunctive use of short-term oral cefcapene therapy alongside standard eyelid hygiene measures resulted in a significant reduction in CSSs in patients with MRKC. However, this reduction was not accompanied by a statistically significant improvement in subjective symptoms.
Insights
Short-term oral cefcapene therapy improved corneal staining in meibomitis-related keratoconjunctivitis (MRKC) patients. While not statistically significant, it showed potential for symptom improvement alongside standard eyelid hygiene.
Area of Science:
- Ophthalmology
- Microbiology
- Pharmacology
Background:
- Meibomitis-related keratoconjunctivitis (MRKC) is a common ocular surface disease.
- Effective treatment strategies for MRKC are crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the clinical characteristics and therapeutic response of MRKC patients treated with oral cefcapene pivoxil hydrochloride hydrate.
- To identify factors associated with favorable outcomes in MRKC treatment.
Main Methods:
- A retrospective analysis of 62 MRKC patients was performed.
- 31 patients received oral cefcapene (100 mg TID) for 14 days with warm compression and lid hygiene.
- Propensity score matching was used to compare cefcapene group with 31 controls receiving standard care.
Main Results:
- The cefcapene group showed a significantly lower mean corneal staining score (CSS) after one month (0.55 ± 0.65) compared to controls (0.86 ± 0.44, P = 0.032).
- Higher rates of complete corneal staining resolution (CSS=0) were observed in the cefcapene group.
- Greater improvement in the Ocular Surface Disease Index (OSDI) was noted in the cefcapene group, but did not reach statistical significance.
Conclusions:
- Adjunctive short-term oral cefcapene therapy significantly reduced CSS in MRKC patients.
- The reduction in CSS was not accompanied by statistically significant improvement in subjective symptoms (OSDI).
- Further research may explore optimal cefcapene treatment durations or combinations for MRKC symptom management.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Microbiome of the Eye

